Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1

NCT06649474 is registered in ClinicalTrials.gov with University Hospital, Clermont-Ferrand as lead sponsor.

NCT NCT06649474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06649474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1
Lead sponsor
University Hospital, Clermont-Ferrand
Phase
Not applicable
Overall status
Recruiting
Start date
September 6, 2024
Completion date
June 30, 2028
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma, oesophagogastric cancer, pancreatic cancer, resectable esophageal cancer, resectable gastric or gastroesophageal junction adenocarcinoma, resectable pancreatic adenocarcinoma